Control Participants (n=21)
Mean ± S.D.
Diabetic Participants
(n=153)
Mean ± S.D.
P
Value
95% Confidence
Interval
Age (years) 13.20 ± 3.17 12.95 ± 3.51 0.757 (-1.35, 1.85)
Free Carnitine (µmol/L) 28.92 ± 7.42 32.32 ± 9.44 0.115 (-7.64, 0.84)
Total Carnitine (µmol/L) 33.78 ± 7.76 36.80 ± 10.76 0.216 (-7.82, 1.78)
Calculated acyl Carnitine (µmol/L) (total-free) 4.86 ± 2.70 4.48 ± 3.48 0.632 (-1.18, 1.94)
Calculated acyl:free ratio
0.20 ± 0.14 0.15 ± 0.14 0.127 (-0.01, 0.11)
Free carnitine/C16 + C18
(CPT-1 activity)
0.20 ± 0.09 0.28 ± 0.11  0.002* (-0.13, -0.03)
C3 (nmol/L) 104.44 ± 44.70 127.44 ± 61.18 0.099 (-50.33, 4.33)
C3-DC (nmol/L) 44.75 ± 18.89     37.16 ± 19.61  0.097    (-1.38, 16.56)
C4 (nmol/L) 121.64 ± 45.85 121.73 ± 72.18 0.996 (-32.08, 31.90)
C5 (nmol/L) 185.26 ± 55.99 177.25 ± 127.21 0.777 (-47.62, 63.64)
C5-DC (nmol/L) 31.63 ± 12.40     37.54 ± 18.22 0.152    (-14.01, 2.19)
C6(nmol/L) 73.82 ± 24.18 65.42 ± 32.23 0.252 (-6.02, 22.82)
C8(nmol/L) 62.45 ± 20.57 84.36 ± 41.46     0.019* (-40.10, -3.72)
C10(nmol/L) 96.07 ± 34.97 130.04 ± 65.89     0.022* (-62.94, -5.00)
C10:1 (nmol/L) 139.13 ± 52.04 134.05 ± 51.84    0.674 (-18.74, 28.90)
C12(nmol/L) 75.09 ± 18.07 75.45 ± 37.51    0.966 (-16.80, 16.08)
C12:1 (nmol/L) 90.82 ± 30.45 79.32 ± 42.55    0.233 (-7.48, 30.48)
C14(nmol/L) 39.09±10.33 38.22 ± 24.05    0.870 (-9.64, 11.38)
C14:1 (nmol/L) 56.01 ±17.13 69.23 ± 38.11    0.119 (-29.89, 3.45)
C16(nmol/L) 79.29 ±15.05 62.21 ± 21.27    < 0.001* (7.60, 26.56)
C16:1 (nmol/L) 53.08 ± 17.56 46.61 ± 22.08    0.200 (-3.45, 16.39)
C16-OH (nmol/L) 17.87  ± 4.21 11.41 ± 11.31     0.011* (1.53, 11.39)
C18(nmol/L) 73.23 ±27.99 64.37 ± 25.96    0.148 (-3.18, 20.90)
C18:1 (nmol/L) 128.17 ± 39.53 130.81 ± 53.07    0.827 (-26.38, 21.10)
C18-OH (nmol/L) 13.67 ± 6.70 36.78 ± 76.71    0.171 (-56.25, 10.03)
C18:1-OH (nmol/L) 17.39 ± 6.64 9.65 ± 3.99    <0.001* (5.73, 9.75)
*significantly different from controls
Table 1: Comparisons of control participants to diabetic participants.